UOC
NPSP

UBS O'Connor’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

UBS O'Connor’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-31,000
Closed -$806K – 780
2014
Q3 		$806K Sell
31,000
-9,000
-23% -$258K 0.01% 362
2014
Q2 		$1.32M Buy
40,000
+25,000
+167% +$722K 0.01% 307
2014
Q1 		$449K Sell
15,000
-35,000
-70% -$1.21M 0.01% 362
2013
Q4 		$1.52M Buy
+50,000
New +$1.38M 0.03% 275
2013
Q3 		– Sell
-60,400
Closed -$912K – 643
2013
Q2 		$912K Buy
+60,400
New +$837K 0.02% 380

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS O'Connor's NPSP Position: Q4 2014 in Review

UBS O'Connor sold out of NPS PHARMACEUTICALS INC (NPSP) in Q4 2014, closing a stake of 31,000 shares — an estimated $806K sold.

UBS O'Connor first reported a position in NPSP in Q2 2013 and held it in 5 quarters. The position peaked at $1.52M in Q4 2013. 213 funds tracked by Wall St. Rank hold NPSP as of Q4 2014.

  • UBS O'Connor reported no remaining NPS PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • UBS O'Connor sold 31,000 NPS PHARMACEUTICALS INC shares in Q4 2014, an estimated $806K.
  • UBS O'Connor first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • UBS O'Connor's NPS PHARMACEUTICALS INC position peaked at $1.52M in Q4 2013.
  • 213 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q4 2014.

Based on UBS O'Connor's 13F filing for Q4 2014, filed 13 Feb 2015.